CKAP4通过抑制Hippo信号通路促进人胶质瘤恶性进展
该研究通过GEPIA和CGGA数据库分析发现CKAP4在胶质瘤中高表达且与患者生存期差相关,利用慢病毒构建敲除或过表达CKAP4的稳定细胞系,在体外和小鼠原位脑肿瘤模型中验证CKAP4通过抑制Hippo信号通路促进胶质瘤恶性进展,提示CKAP4可作为预后生物标志物和潜在治疗靶点。
要点
- CKAP4在胶质瘤中高表达,高表达者生存期更差。
- CKAP4通过抑制Hippo信号通路促进胶质瘤恶性进展。
- 靶向CKAP4可能是胶质瘤治疗的有效策略。
核心结论
- CKAP4有潜力作为预测胶质瘤患者预后的生物标志物,靶向CKAP4表达可能是治疗人胶质瘤的有效策略。
研究设计与样本
- 研究通过GEPIA和CGGA数据库RNA测序数据分析CKAP4表达水平,用慢病毒构建CKAP4敲除或过表达的稳定细胞系,在体外和小鼠原位脑肿瘤模型中研究CKAP4功能,并通过荧光素酶报告基因实验、免疫荧光和免疫印迹探索机制。
主要发现
- CKAP4在胶质瘤中高度上调,高CKAP4表达的肿瘤与患者生存期差相关。
- CKAP4通过抑制Hippo信号通路促进胶质瘤恶性进展。
临床怎么用
- CKAP4高表达与胶质瘤患者生存期差相关,可作为预后判断的潜在生物标志物。
- 靶向CKAP4表达可能成为人胶质瘤治疗的有效策略。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Gliomas are the most common and aggressive malignant brain tumors and are associated with high mortality and incidence in humans. Despite rigorous multi-modal therapy, including surgery, chemotherapy and radiotherapy, patients with malignant glioma survive an average of 12-15 months following primary diagnosis. Therefore, new molecular biomarkers are urgently needed for diagnosis and targeted therapy. Here, we find that suppression of CKAP4 might inhibit glioma growth through regulation of Hippo signaling. METHODS: We examined the expression levels of CKAP4 through analysis of RNA sequencing data from GEPIA and CGGA databases. Then, Lentivirus was used to construct stable cell lines with knockout or overexpression of CKAP4. Next, the function of CKAP4 on glioma was investigated in vitro and in an orthotopic brain tumor model in mice. Lastly, luciferase reporter assay, immunofluorescence and immunoblotting were performed to explore the potential mechanism of how CKAP4 affects gliomas. RESULTS: CKAP4 is highly upregulated in glioma and high CKAP4 expressing tumors were associated with poor patient survival. And CKAP4 promotes malignant progression of gliomas via inhibiting Hippo signaling. CONCLUSION: CKAP4 has potential as a promising biomarker and can predict the prognosis of patients with gliomas. And targeting CKAP4 expression may be an effective therapeutic strategy for the treatment of human gliomas.
引用
- Luo T, Ding K, Ji J, et al. Cytoskeleton-associated protein 4 (CKAP4) promotes malignant progression of human gliomas through inhibition of the Hippo signaling pathway. J Neurooncol. 2021. PMID: 34476666. doi:10.1007/s11060-021-03831-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。